CDC25B and renal cell adenocarcinoma: Overexpression of Cdc25B was found in many malignancies including bladder, gastric, endometrial, and renal cell cancers [30, 31], and cdc25B overexpression was associated with a higher recurrence rate and a poorer prognosis in bladder cancer [32].